Progress Pediatric Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01328288 |
Recruitment Status
:
Completed
First Posted
: April 4, 2011
Last Update Posted
: February 22, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
HIV Depression | Drug: standard ART according to the Thai Ministry of Public Health national guidelines |
Study Type : | Observational |
Actual Enrollment : | 840 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | The Thai Pediatric HIV Disease Progression: An Observational Database |
Study Start Date : | January 2009 |
Actual Primary Completion Date : | September 2015 |
Actual Study Completion Date : | September 2015 |

Group/Cohort | Intervention/treatment |
---|---|
1
long-term follow-up of HIV-infected children
|
Drug: standard ART according to the Thai Ministry of Public Health national guidelines
Patients may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.
|
- HIV related adverse events [ Time Frame: 1 year ]time to HIV related adverse events
- Immunological failure [ Time Frame: 1 year ]time to immunological failure
- virological failure [ Time Frame: 1 year ]time to virological failure
- quality of life [ Time Frame: 1 year ]time to change of quality of life
- depression [ Time Frame: 1 year ]when patient develops depression
- genotypic resistance [ Time Frame: 1 year ]time to genotypic resistance
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | up to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- age < 18 years old
- Have confirmed HIV infection (ELISA,HIV-DNA PCR,HIV-RNA PCR)
- Signed consent form
Exclusion Criteria:
- Hospitalization
- Emergency case
- Incomplete Medical Record

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01328288
Thailand | |
Sanpatong Hospital | |
Sanpathong, Chiang Mai, Thailand | |
HIV-NAT, Thai Red Cross AIDS Research Centre | |
Bangkok, Thailand, 10330 | |
Faculty of Medicine Siriraj Hospital, Mahidol University | |
Bangkok, Thailand | |
Chiangrai Prachanukroh Hospital | |
Chiang Rai, Thailand | |
Bamrasnaradura infectious disease institute | |
Nonthaburi, Thailand, 11000 |
Principal Investigator: | Wisit Prasithsirikul, MD | Bamrasnaradura infectious disease institute | |
Principal Investigator: | Rawiwan Hansudewechakul, MD | Chiangrai Prachanukroh Hospital | |
Principal Investigator: | Wirat Klinbuayam, MD | Sanpatong Hospital | |
Principal Investigator: | Jintanat Ananworanich, MD, PhD | HIV-NAT, Thai Red Cross - AIDS Research Centre | |
Principal Investigator: | Kulkanya Chokephaibulkit, MD | Mahidol University |
Additional Information:
Publications of Results:
Responsible Party: | The HIV Netherlands Australia Thailand Research Collaboration |
ClinicalTrials.gov Identifier: | NCT01328288 History of Changes |
Other Study ID Numbers: |
HIV-NAT 154 |
First Posted: | April 4, 2011 Key Record Dates |
Last Update Posted: | February 22, 2016 |
Last Verified: | February 2016 |
Keywords provided by The HIV Netherlands Australia Thailand Research Collaboration:
HIV related adverse events Immunological failure virological failure |
quality of life depression genotypic resistance |
Additional relevant MeSH terms:
Depression Behavioral Symptoms |